These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [The kallikrein-kinin system and kidney function]. GÅrchev R; Avramova T Eksp Med Morfol; 1988; 27(1):61-7. PubMed ID: 3286220 [No Abstract] [Full Text] [Related]
43. The effect of aprotinin (a serine protease inhibitor) on renal function and renin release. Seto S; Kher V; Scicli AG; Beierwaltes WH; Carretero OA Hypertension; 1983; 5(6):893-9. PubMed ID: 6197374 [TBL] [Abstract][Full Text] [Related]
45. The renal response produced by nonhypotensive sepsis in a large animal model. Walker JF; Cumming AD; Lindsay RM; Solez K; Linton AL Am J Kidney Dis; 1986 Aug; 8(2):88-97. PubMed ID: 3740063 [TBL] [Abstract][Full Text] [Related]
46. Renal function in fulminant hepatic failure: haemodynamics and renal prostaglandins. Guarner F; Hughes RD; Gimson AE; Williams R Gut; 1987 Dec; 28(12):1643-7. PubMed ID: 3322960 [TBL] [Abstract][Full Text] [Related]
47. Effect of sodium nitrite on renal function and sodium and water excretion and brachial and central blood pressure in healthy subjects: a dose-response study. Rosenbaek JB; Al Therwani S; Jensen JM; Mose FH; Wandall-Frostholm C; Pedersen EB; Bech JN Am J Physiol Renal Physiol; 2017 Aug; 313(2):F378-F387. PubMed ID: 28490529 [TBL] [Abstract][Full Text] [Related]
48. Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems. Tsunoda K; Abe K; Omata K; Kudo K; Sato M; Kohzuki M; Tanno M; Seino M; Yasujima M; Yoshinaga K J Clin Hypertens; 1986 Sep; 2(3):263-70. PubMed ID: 3640807 [TBL] [Abstract][Full Text] [Related]
49. [Renal tubular function in cirrhotic patients with ascites: special reference to lithium clearance following the human atrial natriuretic peptide administration]. Ando M Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):791-801. PubMed ID: 1837568 [TBL] [Abstract][Full Text] [Related]
50. Role of kinins and angiotensin II in the renal hemodynamic response to captopril. Mattson DL; Roman RJ Am J Physiol; 1991 May; 260(5 Pt 2):F670-9. PubMed ID: 2035654 [TBL] [Abstract][Full Text] [Related]
51. The effects of ureteral occlusion and renal venous constriction on kidney kallikrein-kinin and prostaglandin systems in dogs. Olsen UB Acta Physiol Scand; 1978 Dec; 104(4):443-52. PubMed ID: 726937 [TBL] [Abstract][Full Text] [Related]
52. Effects of sulindac and naproxen on prostaglandin excretion in patients with impaired renal function and rheumatoid arthritis. Eriksson LO; Sturfelt G; Thysell H; Wollheim FA Am J Med; 1990 Sep; 89(3):313-21. PubMed ID: 2203262 [TBL] [Abstract][Full Text] [Related]
53. The renal kallikrein-kinin system and sodium excretion. Mills IH Q J Exp Physiol; 1982 Jul; 67(3):393-9. PubMed ID: 6921811 [No Abstract] [Full Text] [Related]
54. The role of renal kallikrein and prostaglandin in the control of renin release. Suzuki S; Kobayashi M; Hashiba K Jpn Heart J; 1986 Jan; 27(1):83-93. PubMed ID: 2425102 [TBL] [Abstract][Full Text] [Related]
55. Relationships between sodium clearance, plasma renin activity, plasma aldosterone, renal hemodynamics and blood pressure in essential hypertension. Reubi FC; Weidmann P Clin Exp Hypertens (1978); 1980; 2(3-4):593-612. PubMed ID: 7000463 [TBL] [Abstract][Full Text] [Related]
56. Effects of thromboxane synthesis inhibitor triflusal on renal hemodynamics in microalbuminuric diabetic patients. Esmatjes E; Conget JI; Gaya J; Fernandez MR; Ferrer JP; Rivera F; Vilardell E Diabetes Care; 1990 Nov; 13(11):1114-7. PubMed ID: 2261825 [TBL] [Abstract][Full Text] [Related]
57. Increased urinary 6-keto-PGF1 alpha excretion during water immersion is blunted by metoclopramide in normal man. Minuz P; Coruzzi P; Paluani F; Ravanetti C; Lechi C; Delva P; Lechi A; Novarini A J Endocrinol Invest; 1989 Oct; 12(9):597-600. PubMed ID: 2511238 [TBL] [Abstract][Full Text] [Related]
58. Role of kallikrein-kinin system in the hypotensive mechanisms of converting enzyme inhibitors in essential hypertension. Iimura O; Shimamoto K J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S63-6. PubMed ID: 2474107 [TBL] [Abstract][Full Text] [Related]
59. Renal haemodynamics, sodium and water reabsorption during continuous intravenous infusion of recombinant interleukin-2. Geertsen PF; von der Maase H; Olsen NV; Fogh-Andersen N; Nielsen SL; Leyssac PP Clin Sci (Lond); 1998 Jul; 95(1):73-81. PubMed ID: 9662488 [TBL] [Abstract][Full Text] [Related]
60. Renal excretion of kallikrein and eicosanoids in patients with type 1 (insulin-dependent) diabetes mellitus. Relationship to glomerular and tubular function. Harvey JN; Edmundson AW; Jaffa AA; Martin LL; Mayfield RK Diabetologia; 1992 Sep; 35(9):857-62. PubMed ID: 1397781 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]